Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

MATEDD

Financiado

MRI analysis tool for early detection of dementia

Worldwide due to population ageing there will be 75 million patients with Alzheimer's disease by 2030. Alzheimer's is a disease described by accelerated brain ageing which leads to decline in both memory and cognitive skills, thus... ver más

30/04/2024

NEUROSALIENCE OU

75K€

Presupuesto del proyecto: 75K€

Líder del proyecto

NEUROSALIENCE OU No se ha especificado una descripción o un objeto social para esta compañía.

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2024-04-30

HORIZON-EIE-2022-SCALEUP-02-02: Women TechEU ExpectedOutcome:Project results are expected to contribute to the following expected outcomes:

Innovación

Cerrada hace 2 años

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

NEUROSALIENCE OU

75.00K€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

TEC2008-02113 NUEVAS TECNICAS DE RECONSTRUCCION, PROCESADO, CLASIFICACION... 66K€ Cerrado

TIN2013-47152-C3-2-R DETECCION TEMPRANA DE SINDROMES DE FRAGILIDAD Y DEMENCIA MED... 68K€ Cerrado

TIN2012-33116 INTEGRACION DE DATOS ANATOMICO-FUNCIONALES MEDIANTE MAPAS DE... 116K€ Cerrado

RTC-2017-6682-1 Sistema de modelado 3D automatico para salud [NEXTMED] 198K€ Cerrado

TEC2012-39095-C03-01 BIOMARCADORES BASADOS EN IMAGEN DE RESONANCIA MAGNETICA EN E... 183K€ Cerrado

Duración del proyecto: 11 meses Fecha Inicio: 2023-05-15
Fecha Fin: 2024-04-30

Líder del proyecto

NEUROSALIENCE OU No se ha especificado una descripción o un objeto social para esta compañía.

Presupuesto del proyecto 75K€

Descripción del proyecto Worldwide due to population ageing there will be 75 million patients with Alzheimer's disease by 2030. Alzheimer's is a disease described by accelerated brain ageing which leads to decline in both memory and cognitive skills, thus affecting everyday activities of those suffering. On average over 60% of patients do not receive a diagnosis and average cost of misdiagnosis is estimated to be over 2K €. Existing screening and early diagnostics methods lack speed and accuracy, are not automated enough, and detect only already existing symptoms when it is late for prevention. At Neurosalience we develop a software for assessing brain ageing for early detection of Alzheimer's disease from low-resolution MRI and CT scans. Measuring subject’s brain age and extracting important features for making a prediction are used to assess the risk of Alzheimer's disease. The tool determines whether patient has Alzheimer's along with its stage and type of dementia. We aim at supplying healthcare providers with a more accurate, cheaper and faster early diagnostic tool for Alzheimer's disease. The tool allows decreasing patient-related costs and improving the quality of life of patients. The tool is first in the world to be capable of processing even low-resolution MRI data and providing interpretable results over whole brain. With the support of the Women TechEU programme we will boost the market readiness of the Neurosalience tool by developing the project both from business and regulatory perspectives. For this purpose, we plan to develop a pricing model for the tool, improve deep learning models used in the product and prepare all the documentation along with quality management system required for regulatory approval. We would benefit from the Women TechEU services of mentoring and coaching on how to support and run investor relationships. As we plan to set up partnerships with hospitals, we would also benefit from advice on running such partnerships in the healthcare.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores